These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3470255)

  • 1. Atypical features of primary myelodysplastic syndrome.
    Pati H; Bhargava M; Kochupillai V
    Indian J Med Res; 1986 Nov; 84():516-8. PubMed ID: 3470255
    [No Abstract]   [Full Text] [Related]  

  • 2. The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.
    Grabrucker C; Liepert A; Dreyig J; Kremser A; Kroell T; Freudenreich M; Schmid C; Schweiger C; Tischer J; Kolb HJ; Schmetzer H
    J Immunother; 2010 Jun; 33(5):523-37. PubMed ID: 20463595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WT1 expression levels at diagnosis could predict long-term time-to-progression in adult patients affected by acute myeloid leukaemia and myelodysplastic syndromes.
    Galimberti S; Ghio F; Guerrini F; Ciabatti E; Grassi S; Ferreri MI; Petrini M
    Br J Haematol; 2010 May; 149(3):451-4. PubMed ID: 20085581
    [No Abstract]   [Full Text] [Related]  

  • 4. [Myelodysplastic syndrome--a retrospective study of 38 patients].
    Schrappe-Bächer M; Steffen HM; Maier M; Bernards P; Hoeffken A; Fätkenheuer G
    Med Klin (Munich); 1990 Sep; 85(9):511-6. PubMed ID: 2233608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of telomere erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemia arising from MDS: a marker of disease prognosis?
    Sieglová Z; Zilovcová S; Cermák J; Ríhová H; Brezinová D; Dvoráková R; Marková M; Maaloufová J; Sajdová J; Brezinová J; Zemanová Z; Michalová K
    Leuk Res; 2004 Oct; 28(10):1013-21. PubMed ID: 15289012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum ferritin and disease status at transplantation predict the outcome of allo-SCT in patients with AML or myelodysplastic syndrome.
    Tachibana T; Takasaki H; Tanaka M; Maruta A; Hyo R; Ishigatsubo Y; Kanamori H
    Bone Marrow Transplant; 2011 Jan; 46(1):150-1. PubMed ID: 20383206
    [No Abstract]   [Full Text] [Related]  

  • 7. Analyzing transformation of myelodysplastic syndrome to secondary acute myeloid leukemia using a large patient database.
    Shukron O; Vainstein V; Kündgen A; Germing U; Agur Z
    Am J Hematol; 2012 Sep; 87(9):853-60. PubMed ID: 22674538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and prognostic value of cutaneous manifestations in patients with myelodysplastic syndrome.
    Farah C; Bulai Livideanu C; Jegu J; Paul C; Viraben R; Lamant L; Delavigne K; Adoue D; Laurent G; Beyne Rauzy O
    J Eur Acad Dermatol Venereol; 2010 Oct; 24(10):1171-5. PubMed ID: 20202054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes.
    Hu Q; Dey AL; Yang Y; Shen Y; Jilani IB; Estey EH; Kantarjian HM; Giles FJ; Albitar M
    Cancer; 2004 May; 100(9):1884-91. PubMed ID: 15112269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of beta 2 microglobulin have a prognostic relevance for patients with myelodysplastic syndrome with regard to survival and the risk of transformation into acute myelogenous leukemia.
    Neumann F; Gattermann N; Barthelmes HU; Haas R; Germing U
    Leuk Res; 2009 Feb; 33(2):232-6. PubMed ID: 18639338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelodysplastic syndromes: natural history and features of prognostic importance.
    Mufti GJ; Galton DA
    Clin Haematol; 1986 Nov; 15(4):953-71. PubMed ID: 3552350
    [No Abstract]   [Full Text] [Related]  

  • 12. PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies.
    Duhoux FP; Ameye G; Montano-Almendras CP; Bahloula K; Mozziconacci MJ; Laibe S; Wlodarska I; Michaux L; Talmant P; Richebourg S; Lippert E; Speleman F; Herens C; Struski S; Raynaud S; Auger N; Nadal N; Rack K; Mugneret F; Tigaud I; Lafage M; Taviaux S; Roche-Lestienne C; Latinne D; Libouton JM; Demoulin JB; Poirel HA; ;
    Br J Haematol; 2012 Jan; 156(1):76-88. PubMed ID: 22050763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression signatures of pediatric myelodysplastic syndromes are associated with risk of evolution into acute myeloid leukemia.
    Bresolin S; Trentin L; Zecca M; Giordan M; Sainati L; Locatelli F; Basso G; te Kronnie G
    Leukemia; 2012 Jul; 26(7):1717-9. PubMed ID: 22411123
    [No Abstract]   [Full Text] [Related]  

  • 14. Leukemic cluster growth in culture is an independent risk factor for acute myeloid leukemia and short survival in patients with myelodysplastic syndrome.
    Bernimoulin M; Stern M; Tichelli A; Jotterand M; Gratwohl A; Nissen C
    Acta Haematol; 2008; 119(4):226-35. PubMed ID: 18566541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of immunophenotypic abnormalities of bone marrow myeloid cell compartment in myelodysplastic syndromes.
    Marisavljevic D; Kraguljac-Kurtovic N
    J BUON; 2010; 15(4):746-52. PubMed ID: 21229640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two cases assessed for myeloid disorders had an unexpected twist.
    Reddy KS
    Cancer Genet Cytogenet; 2008 Mar; 181(2):138-40. PubMed ID: 18295667
    [No Abstract]   [Full Text] [Related]  

  • 17. [Trilineage myelodysplasia].
    Kuriyama K
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):209-12. PubMed ID: 9851123
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognosis of secondary acute myeloid leukemia is affected by the type of the preceding hematologic disorders and the presence of trisomy 8.
    Koh Y; Kim I; Bae JY; Song EY; Kim HK; Yoon SS; Lee DS; Park SS; Park MH; Park S; Kim BK
    Jpn J Clin Oncol; 2010 Nov; 40(11):1037-45. PubMed ID: 20587614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the prognostication and management of advanced MDS in children.
    Hasle H; Niemeyer CM
    Br J Haematol; 2011 Jul; 154(2):185-95. PubMed ID: 21554264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current treatment options for myelodysplastic syndromes].
    Nolte F; Hofmann WK
    Dtsch Med Wochenschr; 2010 Sep; 135(38):1863-9. PubMed ID: 20842606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.